United States Considers Modifying its Drug Stockpile
A variety of H1N1 influenza virus appears to be the leading flu that is spreading now and all of the H1N1 strains, which were tested in North America, were resistant to tamiflu. Other influenza viruses thankfully have not shown the same inclination to resistance however the possibility that tamiflu may be compromised has made some governments reconsider their own stockpiles of drugs and their reliance on tamiflu.
In the United States, the Department Of Health And Human Services is thinking about modifying the makeup of their national stockpile of antivirals, which contains eighty percent tamiflu and twenty percent Relenza. The government of Great Britain has upgraded their own stockpile by adding 10 million added doses of Relenza since it has not yet shown any resistance trouble, as has tamiflu.
Tamiflu comprises the majority of in each of the national antiviral stockpile of Canada, which is sustained at the National level and national emergency stockpile. Both of these stores of drugs maintained by the federal government are expected to be able to treat one quarter of the population in the event of a pandemic. This number seems to equal what other countries have warehoused while Britain has stored enough antivirals for half of their population.